ANALYSIS: Why do shareholders appoint a patsy to their boards just before their companies fail?
The cancer diagnostics company has been undercapitalised from the get-go.
The reality of the wine industry is not as glossy as its marketing suggests, some growers say.
42 Below and Ecoya made money for investors eventually but their creators are struggling with beer marketer Moa.
Shoeshine: Shareholders have little choice but to hope a huge rights issue will rescue their company.
Should New Zealand’s accounting firms be heading for higher ground?
SHOESHINE: The mānuka honey specialist keeps finding excuses for poor performance.
Shoeshine: Would throwing more money at white-collar crimebusters help make the system more just?
Shoeshine: High-growth companies don’t need stock exchanges any more.
Shoeshine: Pass the bubbly, darling, it's time to celebrate. Or commiserate. Or something.